Bio-resilience as Collective Security Infrastructure

The COVID-19 pandemic and the subsequent reassessment of biological threats in the context of geopolitical competition have accelerated a structural shift in how European institutions conceptualise health security. Medical countermeasures—vaccines, therapeutics, diagnostics, and associated detection and protection capabilities—are increasingly treated not solely as instruments of public health policy but as components of collective security infrastructure. In this perspective, bio-resilience becomes analogous to energy resilience or cyber resilience: a system-level capacity that combines surveillance, industrial production, logistics, and coordinated governance to maintain societal and operational continuity under biological disruption. Within the European Union, this shift is visible in the creation of the Health Emergency Preparedness and Response Authority (HERA), the development of EU-level stockpiling strategies, and the expansion of the rescEU reserve framework. Parallel developments within NATO, particularly through its medical and CBRN preparedness structures, indicate a growing recognition that biological threats—whether naturally occurring, accidental, or deliberate—have direct implications for alliance readiness and civil-military continuity.

Against this background, the report examines the emergence of a European medical countermeasures ecosystem that functions as a defence-adjacent industrial and institutional architecture linking EU health-security mechanisms with NATO’s operational readiness framework. The analysis first establishes the strategic context in which bio-resilience has become a security concern rather than a purely public-health matter. It then reconstructs the institutional architecture built around HERA, the EU stockpiling strategy, and rescEU reserves, explaining how these mechanisms form a layered capability stack. The core of the report analyses four interdependent capability blocks: biosurveillance and health intelligence; scalable development and manufacturing capacity; coordinated strategic stockpiling and logistics; and CBRN medical preparedness integrating detection, decontamination, and medical response. Subsequent sections translate these capabilities into the industrial ecosystem required to sustain them, examine stockpiling as operational infrastructure, and analyse civil–military interoperability in CBRN preparedness. The report concludes by assessing governance, financing, and security-of-supply mechanisms that determine whether the emerging architecture can function as a durable element of European collective security.